Connie L Celum MD

Infectious Disease•Seattle, WA

Professor, Global Health and Community Medicine, University of Washington School of Medicine

Join to View Full Profile

325 9th AveSeattle, WA 98104
Phone+1 206-744-3000

Education & Training

University of WashingtonFellowship, Infectious Disease, 1989 - 1991
University of California San Francisco School of MedicineClass of 1984, MD

Certifications & Licensure

CA State Medical License 1985 - Present
WA State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Study of the Effects of Advantage 24 on the Rectum
Completed
Phase 1
A Study of HIV in Newly Infected Individuals
Completed
A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1 Start of enrollment: 1999 Aug 01
Completed
Effects of BufferGel and PRO 2000/5 Gel in Men
Completed
Phase 1
HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru
Completed
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials Start of enrollment: 2002 Apr 01
Completed
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes Start of enrollment: 2005 Apr 01
Completed
Phase 3
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission Start of enrollment: 2004 Nov 01
Completed
Phase 3
Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) Start of enrollment: 2006 Sep 01
Completed
Phase 2
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men. Start of enrollment: 2003 Aug 01
Completed
Phase 3
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons Start of enrollment: 2005 Jan 01
Completed
Phase 3
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples Start of enrollment: 2008 May 01
Completed
Phase 3
GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons Start of enrollment: 2010 Feb 01
Completed
Phase 4
Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa Start of enrollment: 2013 Jun 01
Completed
Not Applicable
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study Start of enrollment: 2016 Oct 12
Completed
Phase 4
HIV Self Testing of Male Partners of Women in PMTCT Start of enrollment: 2018 May 17
COMPLETED
NA
The Prevention Options for Women Evaluation Research (POWER) Cohort Start of enrollment: 2017 Jun 14
Completed
The PrEP (Pre-exposure Prophylaxis) SMART Study Start of enrollment: 2019 May 16
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Impact of male peer-led outreach on uptake of HIV testing among male partners of pregnant women in Uganda: a randomized trial.
Faith Naddunga, Michelle A Bulterys, Agnes Nakyanzi, Deborah Donnell, Juliet Kyomugisha
Journal of the International AIDS Society. 2025-04-01
1 citations
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and op...
Anne F Luetkemeyer, Deborah Donnell, Stephanie E Cohen, Julia C Dombrowski, Cole Grabow
The Lancet. Infectious Diseases. 2025-03-24
2 citations
In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis.
Lauren C Tantalo, Anne F Luetkemeyer, Nicole A P Lieberman, B Ethan Nunley, Carlos Avendaño
The Journal of Infectious Diseases. 2025-03-17

Journal Articles

Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact
Connie Celum, Myron S Cohen, Wafaa El-Sadr, The New England Journal of Medicine
Quadrivalent HPV Vaccine in HIV-1-Infected Early Adolescent Girls and Boys in Kenya: Month 7 and 12 Post Vaccine Immunogenicity and Correlation with Immune Status
Linda Eckert, Connie Celum, Jared M Baeten, ScienceDirect
Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships
Elizabeth R Brown, Jessica E Haberer, Connie Celum, Jared M Baeten, AIDS and Behavior

Press Mentions

"Glimmer of Hope": STI Surge Shows First Signs of Slowing in Decades. What’s Behind the Trend?January 17th, 2025
Widely Available Antibiotic Helps Prevent Bacterial STIs in Certain Populations, UW Clinical Trial FindsJune 6th, 2022
Young Women and Pregnant Women Can Effectively Use Vaginal Rings and Oral PrEP for HIV PreventionJuly 28th, 2021
Join now to see all

Grant Support

The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratiosUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratiosUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
University of Washington/Fred Hutch Center for AIDS ResearchUNIVERSITY OF WASHINGTON1997–2028
University of Washington/Fred Hutch Center for AIDS ResearchUNIVERSITY OF WASHINGTON1997–2028
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with menUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025
Interventions To Decrease HIV Infectiousness In UgandaNational Institute Of Allergy And Infectious Diseases2010–2012
Multi-Component, Targeted HIV Prevention For Sub-Saharan Africa: PreventionrxNational Institute Of Allergy And Infectious Diseases2009–2012
Acyclovir To Prevent HIV Acquisition In Hsv-2+ PersonsNational Institute Of Allergy And Infectious Diseases2005–2007
STDS And Heterosexual 'Bridging'Among Men WHO Have SexNational Institute Of Allergy And Infectious Diseases2001–2006
Acylovir To Prevent HIV Acquisition In Hsv-2+PersonsNational Institute Of Allergy And Infectious Diseases2002–2004
STDS And Heterosexual Bridging Among Men WHO Have SexNational Institute Of Allergy And Infectious Diseases2000